Eildon Capital Group (EDC)

Overview

RegenETP, Inc. is a forward-thinking biotechnology entity immersed in the clinical stage, fundamentally engaged in developing and bringing to market a wide array of regenerative tissue products and biomaterials. This initiative spans across critical fields such as medicine, biomedical engineering, and material sciences, predominantly within the United States. The company operates through two main segments: Regenerative Medicine Products and Contract Services, marking its presence with innovative solutions. Originally operating under the name PolarityTE, Inc., it underwent a strategic rebranding to RegenETP, Inc. in August 2023. Positioned strategically in Salt Lake City, Utah, the company is spearheading the way towards groundbreaking regenerative treatments and services.

Products and Services

• SkinTE

A revolutionary tissue product, SkinTE stands at the forefront of RegenETP, Inc.'s offerings. It is ingeniously designed for the repair, reconstruction, replacement, and supplementation of skin. This makes it a highly sought-after solution for treating acute or chronic wounds, burns, and undergoing surgical reconstructions, scar revisions, or the removal of dysfunctional skin grafts. SkinTE embodies the company's commitment to advancing regenerative medicine by addressing a broad spectrum of skin-related issues.

• SkinTE Cryo

Building on the foundation of SkinTE, SkinTE Cryo introduces an innovative cryopreservation process that enables multiple deployments from a single original harvest. This enhancement not only maximizes the utility of harvested tissues but also extends the applicability of SkinTE by ensuring its prolonged availability and use. It represents a significant technological advancement in tissue preservation and utilization, reflecting RegenETP, Inc.'s dedication to pioneering new methods in regenerative therapy.

• SkinTE Point-of-Care Device

The SkinTE point-of-care device is another critical innovation from RegenETP, Inc. This device facilitates the processing and deployment of SkinTE right after the initial harvest at the care point. It underscores the company's focus on enhancing the accessibility and immediacy of regenerative treatments, ensuring that patients receive the most efficient and effective care possible. This device is a testament to RegenETP's ongoing mission to streamline and optimize regenerative medical interventions.

• Contract Research Services

Aside from its flagship products, RegenETP, Inc. also offers contract research services, providing comprehensive support in the field of regenerative medicine. These services cater to the burgeoning needs of research and development within this specialized sector, offering expertise and technical know-how to help drive innovation and discovery. With a focus on collaboration and advancement, RegenETP's contract research services play a pivotal role in fostering new therapies and technologies in regenerative medicine.

• Other Tissue Regeneration Products

Looking beyond its primary offerings, RegenETP, Inc. is also engaged in the development of a diverse portfolio of other tissue regeneration products. Each of these is aimed at addressing various challenges within regenerative medicine and biomedical engineering. By continuously expanding its product lineup, the company is committed to meeting the evolving needs of the medical community and patients alike, ultimately contributing to the broader goal of improving healthcare outcomes through innovative regenerative solutions.